Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon S Park

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Surgery|November 29, 2025
Does spending for subspecialty care in advanced-stage melanoma matter: Are greater access costs actually associated with increased use of immune therapy and improved survival among patients with low income?Simon S Park, Raymond A Verm, Diane D Park, et al.
Biosensors & Bioelectronics|September 22, 2014
A plasmon-assisted fluoro-immunoassay using gold nanoparticle-decorated carbon nanotubes for monitoring the influenza virusJaewook Lee, Syed Rahin Ahmed, Sangjin Oh, et al.
Surgery|November 26, 2024
Localized hepatocellular carcinoma: Is liver-directed therapy alone as efficacious as surgical resection?Karina C Geranios, Michael J Littau, Simon S Park, et al.
RSC Advances|October 29, 2024
Intact quantitation and evaluation of a PEG-glycosulfopeptide as a therapeutic P-selectin antagonistDiane D Park, Simon S Park, Erbin Dai, et al.
American Journal of Surgery|December 26, 2023
Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?Simon S Park, Raymond A Verm, Zaid M Abdelsattar, et al.
Surgery|October 20, 2023
Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?Simon S Park, Raymond A Verm, Zaid M Abdelsattar, et al.
Science Advances|October 28, 2022
Identification and characterization of circulating immune complexes in IgA nephropathyYasuyuki Matsumoto, Rajindra P Aryal, Jamie Heimburg-Molinaro, et al.
Cell Chemical Biology|July 18, 2023
Chemokine binding to PSGL-1 is controlled by O-glycosylation and tyrosine sulfationChristoffer K Goth, Akul Y Mehta, Alyssa M McQuillan, et al.
Blood|May 4, 2021
A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasisDaniel J Wong, Diane D Park, Simon S Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2020
Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycansDiane Dayoung Park, Chatchai Phoomak, Gege Xu, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Surgery|November 29, 2025
Does spending for subspecialty care in advanced-stage melanoma matter: Are greater access costs actually associated with increased use of immune therapy and improved survival among patients with low income?Simon S Park, Raymond A Verm, Diane D Park, et al.
Biosensors & Bioelectronics|September 22, 2014
A plasmon-assisted fluoro-immunoassay using gold nanoparticle-decorated carbon nanotubes for monitoring the influenza virusJaewook Lee, Syed Rahin Ahmed, Sangjin Oh, et al.
Surgery|November 26, 2024
Localized hepatocellular carcinoma: Is liver-directed therapy alone as efficacious as surgical resection?Karina C Geranios, Michael J Littau, Simon S Park, et al.
RSC Advances|October 29, 2024
Intact quantitation and evaluation of a PEG-glycosulfopeptide as a therapeutic P-selectin antagonistDiane D Park, Simon S Park, Erbin Dai, et al.
American Journal of Surgery|December 26, 2023
Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?Simon S Park, Raymond A Verm, Zaid M Abdelsattar, et al.
Surgery|October 20, 2023
Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?Simon S Park, Raymond A Verm, Zaid M Abdelsattar, et al.
Science Advances|October 28, 2022
Identification and characterization of circulating immune complexes in IgA nephropathyYasuyuki Matsumoto, Rajindra P Aryal, Jamie Heimburg-Molinaro, et al.
Cell Chemical Biology|July 18, 2023
Chemokine binding to PSGL-1 is controlled by O-glycosylation and tyrosine sulfationChristoffer K Goth, Akul Y Mehta, Alyssa M McQuillan, et al.
Blood|May 4, 2021
A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasisDaniel J Wong, Diane D Park, Simon S Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2020
Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycansDiane Dayoung Park, Chatchai Phoomak, Gege Xu, et al.
Pageof 4